Publication:
Editorial: Signaling pathways behind immune evasion and therapy resistance

Thumbnail Image
Files
E_Martin_Orozco et al 2022_fimmu_Editorial.pdf(285.77 KB)
Date
2022-12-09
relationships.isAuthorOfPublication
Profile Picture
Person
relationships.isSecondaryAuthorOf
relationships.isDirectorOf
Authors
Wang, Lisheng ; Chatterjee, Shilpak ; Hanks, Brent A ; Martín-Orozco Santiago, María Elena
item.page.secondaryauthor
item.page.director
Publisher
Frontiers
publication.page.editor
publication.page.department
Bioquímica y Biología Molecular B e Inmunología
DOI
10.3389/fimmu.2022.1104167
item.page.type
info:eu-repo/semantics/article
Description
©2022. This manuscript version is made available under the CC-BY 4.0 license http://creativecommons.org/licenses/by /4.0/ This document is the Published, version of a Published Work that appeared in final form in Frontiers in Immunology. To access the final edited and published work see 10.3389/fimmu.2022.1104167
Abstract
publication.page.subject
Tumor immunity, , PD-L1, , cAMP , UPR , PDE4B , N6-methyladenosine , QCRC1 , PDIA5
Citation
Frontiers in Immunology13:1104167
URI
http://hdl.handle.net/10201/138030
item.page.embargo
Collections
Artículos
Ir a Estadísticas